AzTrials
AzTrials

Flexor Digitorum Profundus InjuryNCT03812978

Mobile Application for Improving Rehabilitation After Flexor Tendon Repair

A study testing Smart phone application in people with Flexor Digitorum Profundus Injury, run by Karolinska Institutet at 4 sites in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Can a mobile application improve adherence, self-efficacy and range of motion after flexor tendon repair? A randomized controlled multicenter trial. Aim Evaluate how the use of a mobile application will affect exercise adherence, range of motion and self-efficacy when compared to standard rehabilitation after flexor… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Flexor Digitorum Profundus Injury
What is being tested?
Smart phone application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
101 participants
Where
4 sitesSweden
Study dates
1 Mar 2017to 10 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Over 18 years old,
  • Own a mobile phone, fluent in Swedish,
  • Suited for early active motion rehabilitation
  • Injury to one or both of the flexor tendons in the a finger

Who cannot join

  • concomitant fracture in the hand
  • tendon injury to flexor pollicis longus.
  • Extensor tendon injury in the same hand.

Trial locations and contacts

4 sites in 1 country.

Sweden4 sites
  • Department of hand surgery, Skåne university hospital

    Malmö

  • Department of hand surgery, University hospital Örebro

    Örebro

  • Department of hand surgery, Södersjukshuset

    Stockholm

  • Department of hand surgery, Uppsala university hospital

    Uppsala

Other trials in Sweden

About this study

Official title: Mobile Application for Improving Rehabilitation After Flexor Tendon Repair - A Randomized Controlled Multicenter Trial.

Can a mobile application improve adherence, self-efficacy and range of motion after flexor tendon repair? A randomized controlled multicenter trial.

Aim Evaluate how the use of a mobile application will affect exercise adherence, range of motion and self-efficacy when compared to standard rehabilitation after flexor tendon repair. Method Multicenter randomized controlled trial. Patients with flexor tendon repair in zone I or II were included and rehabilitated with early active motion and followed 12 weeks post-surgery. Randomization was performed by a computer-generated concealed block to control (n=60) or intervention group (n=60). Both groups received standard rehabilitation according to early active motion. Intervention group also received a smart phone app including; exercise videos, push-notifications for exercise, exercise diary, written information on the surgery, rehabilitation, questions and answers. Evaluation was made at baseline, 2, 6- and 12-weeks after surgery. Primary outcome was physiotherapist rated adherence on the Sport Injury Adherence Scale (SIRAS). Secondary outcome was self-reported adherence, perceived self-efficacy, total Active range of motion (TAM) in the Proximal Interphalangeal (PIP) joint and Distal Interphalangeal (DIP) joint and perceived satisfaction with rehabilitation and information.

Being tested
Smart phone application
Keywords
"Flexor tendon rehabilitation", "Smart-phone application", "adherence"

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smart phone applicationOther

    Smart phone application including exercise videos, push notifications for exercise, questions and answers, exercise diary.

Study groups in NCT03812978
Study groupRoleWhat they receive
ControlNo interventionStandard treatment
InterventionExperimentalStandard treatment and intervention (Smart phone application)
Receives: Other: Smart phone application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sport injury adherence scale (SIRAS)

    Physiotherapist rated adherence questionnaire

    Measured: assessed at 2 weeks (totalt score range 3-15, higher value indicates better outcome)

  2. Sport injury adherence scale (SIRAS)

    Physiotherapist rated adherence questionnaire

    Measured: assessed at 6 weeks (totalt score range 3-15, higher value indicates better outcome)

Secondary outcomes (5)
  1. Self reported adherence

    Patient rated adherence questionnaire duration

    Measured: assessed at 2 and 6 weeks (total score range 0-100,higher value indicates better outcome )

  2. Self reported adherence

    Patient rated adherence questionnaire frequency

    Measured: assessed at 2 and 6 weeks (total score range 0-100,higher value indicates better outcome )

  3. Self reported adherence

    Patient rated adherence questionnaire quality

    Measured: assessed at 2 and 6 weeks (total score range 0-100, higher value indicates better outcome)

  4. Athlet injury self efficacy questionnaire (AISEQ)

    Patient reported self efficacy for rehabilitation

    Measured: baseline, 2 and 6 weeks (Change over time)

  5. Range of motion

    Total range of motion in the proximal interphalangeal and distal interphalangeal joints measured with a finger goniometer

    Measured: assessed at 12 weeks (range 0-240,higher value indicates better outcome )

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2019
  2. Study start1 Mar 2017
  3. Primary completion10 May 2019
  4. Study completion10 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03812978
Sponsor's protocol ID
FlexortendonsSOS2018
Status last verified
Aug 2019
First submitted
15 Jan 2019
Last updated
20 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Smart phone application in people with Flexor Digitorum Profundus Injury, run by Karolinska Institutet at 4 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sport injury adherence scale (SIRAS) (time frame: assessed at 2 weeks (totalt score range 3-15, higher value indicates better outcome)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in